Banner - Collaborative Care Symposium
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Kent Uehara, OD, FAAO

Advertisement

Articles by Kent Uehara, OD, FAAO

Reviewing a patient’s systemic history is critical when treating for OSD

ByKent Uehara, OD, FAAO,Katherine M. Mastrota, MS, OD, FAAO, Dipl ABO
January 17th 2023

Staying up-to-date on all things ocular is imperative in ocular surface disease.

Advertisement

Latest Updated Articles

  • Reviewing a patient’s systemic history is critical when treating for OSD
    Reviewing a patient’s systemic history is critical when treating for OSD

    Published: January 17th 2023 | Updated:



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

FDA CRL for SYD-101 sparks AAOMC statement on significance of myopia control

2

Retinal ganglion cells: What they can tell us and why we should listen

3

Study maps thermal dynamics of glaucoma laser treatments

4

NCX 470 advances toward US, China NDA submissions for NCX 470

5

FDA extends Aldeyra's reproxalap PDUFA after requesting additional clinical study report

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us